Investing Profile

Mike Dial

Photo of Mike Dial, Partner at Hatteras Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$400K - $4.0M
$2.0M
7
$94M
CompanyStageDateRound SizeTotal Raised
Ten63 Therapeutics
Series UnknownFeb 2026
$16M
Co-investors: Po Bronson (SOSV), Arvind Gupta (Mayfield Fund), Clay Thorp (Hatteras Venture Partners), John Gustofson (AbbVie Ventures)
Ribometrix
Series ANov 2018$30M
SeedOct 2017$8M
$38M
Co-investors: John Gustofson (AbbVie Ventures)
G1 Therapeutics
Series CMay 2016$47M
Series BFeb 2015$33M
$93M
Co-investors: Peter Kolchinsky (RA Capital), Christy Shaffer (Hatteras Venture Partners)
Viamet Pharmaceuticals
Series DOct 2014$60M
Series BJul 2009$25M
$89M
Co-investors: Douglas Reed (AttorneyAlert)